Personal information

Other IDs

Loop profile: 614029
SciProfiles: 1083027

Activities

Collapse all

Employment (2)

Institute of Chemical Biology and Fundamental Medicine: Novosibirsk, RU

2014-11-13 to present (Nucleic Acids Biochemistry)
Employment
Source: Self-asserted source
Svetlana Miroshnichenko (Gaponova)

Institute of Chemical Biology and Fundamental Medicine: Novosibirsk, RU

2017-10-01 to 2020-11-20 | PhD
Employment
Source: Self-asserted source
Svetlana Miroshnichenko (Gaponova)

Education and qualifications (2)

Novosibirsk State University: Novosibirsk, RU

2015-09-01 to 2017-08-31 | Master (Natural Sciences)
Education
Source: Self-asserted source
Svetlana Miroshnichenko (Gaponova)

Novosibirsk State University: Novosibirsk, RU

2011-09-01 to 2015-08-31 | Bachelor (Natural Sciences)
Education
Source: Self-asserted source
Svetlana Miroshnichenko (Gaponova)

Works (10)

Single Shot vs. Cocktail: A Comparison of Mono- and Combinative Application of miRNA-Targeted Mesyl Oligonucleotides for Efficient Antitumor Therapy

Cancers
2022-09 | Journal article | Author
DOI: 10.3390/cancers14184396
Contributors: Svetlana Miroshnichenko (Gaponova); Olga Patutina; Alexandra Sen'kova; Ekaterina Burakova; Innokenty Savin; Andrey Markov; Elena Shmendel; Mikhail Maslov; Dmitry Stetsenko; Valentin Vlassov et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Bulge-Forming miRNases Cleave Oncogenic miRNAs at the Central Loop Region in a Sequence-Specific Manner

International Journal of Molecular Sciences
2022-06 | Journal article | Author
DOI: 10.3390/ijms23126562
Contributors: Olga Patutina; Daria Chiglintseva; Bahareh Amirloo; David Clarke; Svetlana Miroshnichenko (Gaponova); Valentin Vlassov; Elena Bichenkova; Marina Zenkova
Source: check_circle
Multidisciplinary Digital Publishing Institute

Site-Selective Artificial Ribonucleases: Renaissance of Oligonucleotide Conjugates for Irreversible Cleavage of RNA Sequences.

Molecules (Basel, Switzerland)
2021-03-19 | Journal article
DOI: 10.3390/molecules26061732
PMID: 33808835
Source: Self-asserted source
Svetlana Miroshnichenko (Gaponova)

Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency.

Proceedings of the National Academy of Sciences of the United States of America
2020-12-07 | Journal article
DOI: 10.1073/pnas.2016158117
PMID: 33288723
Source: Self-asserted source
Svetlana Miroshnichenko (Gaponova)

Dual miRNases for Triple Incision of miRNA Target: Design Concept and Catalytic Performance.

Molecules (Basel, Switzerland)
2020-05-25 | Journal article
DOI: 10.3390/molecules25102459
PMID: 32466298
PMC: PMC7287882
Source: Self-asserted source
Svetlana Miroshnichenko (Gaponova)

Catalytic Knockdown of miR-21 by Artificial Ribonuclease: Biological Performance in Tumor Model.

Frontiers in pharmacology
2019-08-08 | Journal article
DOI: 10.3389/fphar.2019.00879
PMID: 31456683
PMC: PMC6698794
Source: Self-asserted source
Svetlana Miroshnichenko (Gaponova)

Enhanced Inhibition of Tumorigenesis Using Combinations of miRNA-Targeted Therapeutics.

Frontiers in pharmacology
2019-05-16 | Journal article
DOI: 10.3389/fphar.2019.00488
PMID: 31156429
PMC: PMC6531850
Source: Self-asserted source
Svetlana Miroshnichenko (Gaponova)

Mesyl phosphoramidate antisense oligonucleotides as an alternative to phosphorothioates with improved biochemical and biological properties.

Proceedings of the National Academy of Sciences of the United States of America
2019-01-08 | Journal article
DOI: 10.1073/pnas.1813376116
PMID: 30622178
PMC: PMC6347720
Source: Self-asserted source
Svetlana Miroshnichenko (Gaponova)

Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H.

Scientific reports
2018-10-09 | Journal article
DOI: 10.1038/s41598-018-33331-z
PMID: 30302012
PMC: PMC6177439
Source: Self-asserted source
Svetlana Miroshnichenko (Gaponova)
grade
Preferred source (of 2)‎

miRNases: Novel peptide-oligonucleotide bioconjugates that silence miR-21 in lymphosarcoma cells.

Biomaterials
2017-01-13 | Journal article
DOI: 10.1016/j.biomaterials.2017.01.018
PMID: 28126663
Source: Self-asserted source
Svetlana Miroshnichenko (Gaponova)
grade
Preferred source (of 2)‎
How many people are using ORCID?